Majetschak Matthias, Obertacke Udo, Schade F Ulrich, Bardenheuer Mark, Voggenreiter Gregor, Bloemeke Brunhilde, Heesen Michael
Department of Trauma Surgery, University Hospital Mannheim, Ruprecht-Karls-University Heidelberg, 68167 Mannheim, The Netherlands.
Clin Diagn Lab Immunol. 2002 Nov;9(6):1205-11. doi: 10.1128/cdli.9.6.1205-1211.2002.
The tumor necrosis factor alpha (TNF-alpha) -308 G/A and TNF-beta NcO1 polymorphisms have been described to be associated with an increased risk for sepsis in critically ill patients. Functional consequences associated with these polymorphisms remain unclear. We compared the genotype distribution of these TNF polymorphisms with susceptibility to severe sepsis and leukocyte function in blunt trauma patients (n = 70; mean injury severity score, 24 points [range, 4 to 57). Severe sepsis was defined according to the American College of Chest Physicians-Society of Critical Care Medicine consensus conference criteria. Genotyping for the NcO1 polymorphism (alleles TNFB1 and TNFB2) was performed by PCR and digestion of the products with NcO1, and that for the TNF-alpha -308 G/A polymorphism (alleles TNF1 and TNF2) was performed by real-time PCR. Leukocyte function was assessed by measurement of the production of endotoxin-induced cytokines (TNF-alpha, interleukin-6 [IL-6], and IL-8) in whole blood. TNF-alpha, IL-6, and IL-8 were determined by enzyme-linked immunosorbent assay. For the genotypes of the TNF-alpha -308 G/A polymorphism, differences in the frequency of development of severe sepsis were not detectable. Patients developing severe sepsis after trauma were significantly more likely to possess a homozygous genotype of the TNF-beta NcO1 polymorphism. Compared with heterozygotes, the odds ratio for the TNFB2/B2 genotype for the development of severe posttraumatic sepsis was 11 (P = 0.01), and that for the TNFB1/B1 genotype was 13 (P = 0.014). TNF-alpha -308:TNF-beta NcO1 haplotype analysis showed that the TNFB2:TNF2 haplotype is significantly negatively associated with development of severe sepsis. Patients homozygous for the TNFB1 or TNFB2 allele showed a persistently higher cytokine-producing capacity during at least 4 to 8 days after trauma than the heterozygotes. In patients homozygous for the TNF1 allele, a higher TNF-alpha- and IL-8-producing capacity was found only at day 1 after trauma. Although the TNF-beta NcO1 polymorphism appears to be less likely to be causative for development of severe sepsis after trauma, it is thus far the only genetic marker identified which can be used as a relevant risk estimate for severe sepsis in trauma patients immediately after the injury.
肿瘤坏死因子α(TNF-α)-308 G/A和肿瘤坏死因子β NcO1基因多态性已被描述为与重症患者发生脓毒症的风险增加相关。与这些多态性相关的功能后果仍不清楚。我们比较了这些TNF基因多态性的基因型分布与钝性创伤患者(n = 70;平均损伤严重程度评分,24分[范围,4至57])发生严重脓毒症的易感性及白细胞功能。严重脓毒症根据美国胸科医师学会-危重病医学会共识会议标准定义。通过PCR及用NcO1酶切产物对NcO1基因多态性(等位基因TNFB1和TNFB2)进行基因分型,通过实时PCR对TNF-α -308 G/A基因多态性(等位基因TNF1和TNF2)进行基因分型。通过测量全血中内毒素诱导的细胞因子(TNF-α、白细胞介素-6 [IL-6]和IL-8)的产生来评估白细胞功能。通过酶联免疫吸附测定法测定TNF-α、IL-6和IL-8。对于TNF-α -308 G/A基因多态性的基因型,未检测到严重脓毒症发生频率的差异。创伤后发生严重脓毒症的患者更有可能拥有TNF-β NcO1基因多态性的纯合基因型。与杂合子相比,TNFB2/B2基因型发生严重创伤后脓毒症的比值比为11(P = 0.01),TNFB1/B1基因型的比值比为13(P = 0.014)。TNF-α -308:TNF-β NcO1单倍型分析表明,TNFB2:TNF2单倍型与严重脓毒症的发生显著负相关。TNFB1或TNFB2等位基因纯合的患者在创伤后至少4至8天内的细胞因子产生能力持续高于杂合子。在TNF1等位基因纯合的患者中,仅在创伤后第1天发现较高的TNF-α和IL-8产生能力。尽管TNF-β NcO1基因多态性似乎不太可能是创伤后严重脓毒症发生的病因,但它是迄今为止确定的唯一可作为创伤患者受伤后立即发生严重脓毒症相关风险评估的遗传标志物。